Skip to content

Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia

Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia: a Randomized Double-blind Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03720249
Enrollment
100
Registered
2018-10-25
Start date
2019-05-20
Completion date
2022-12-31
Last updated
2019-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperhomocysteinemia

Brief summary

The purpose of this study is to determine whether supplementation of compound nutrients,including folic acid, vitamin B6, vitamin B12, betaine and zinc, will decrease the level of plasma homocysteine in Chinese adults with hyperhomocysteinemia.

Interventions

Betaine、 (6S)-5-methyltetrahydrofolic acid、vitamin B6、vitamin B12 and zinc per day orally for 12 weeks.

DIETARY_SUPPLEMENTplacebo control

The placebo is an excipient and the color, flavor, shape, taste and weight are same with the tablet of supplement.

Sponsors

Huilian Zhu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. People aged 18-65 years. 2. The level of plasma homocysteine is 15-100μmol/L. 3. Free from products which could decrease plasma homocysteine for at least one month. 4. Willing to participate in the study, consume the test product and perform all measurements.

Exclusion criteria

1. pregnant or lactating women. 2. severe diseases need to control. 3. people who unconsciousness and can not complete questionnaire. 4. long-term regular use of vitamin or mineral supplements.

Design outcomes

Primary

MeasureTime frameDescription
levels of homocysteine12 weeksAt baseline, 4 weeks and 12 weeks, blood samples will be drawn and levels of homocysteine will be tested in two groups.

Secondary

MeasureTime frameDescription
levels of 5-methyltetrahydrofolic acid, vitamin B6, vitamin B12 and betaine12 weeksAt baseline, 4 weeks and 12 weeks, blood samples will be drawn and levels of 5-methyltetrahydrofolic acid, vitamin B6, vitamin B12 and betaine will be tested in two groups.
levels of s-adenosyl-methionine and s-adenosyl-homocysteine12 weeksAt baseline, 4 weeks and 12 weeks, blood samples will be drawn and levels of s-adenosyl-methionine (SAM) and s-adenosyl-homocysteine (SAH) will be tested in two groups.
anthropomorphic measurements and blood biochemical markers12 weeksAnthropomorphic measurements such as height, weight, waist circumference, hip circumference, vascular endothelial function, cardiopulmonary function, body composition and so on, and blood biochemical markers such as overnight fasting serum total cholesterol (TC), triglyceride (TG), LDL cholesterol (LDLc), HDL cholesterol (HDLc), fasting blood glucose and so on will be measured.

Countries

China

Contacts

Primary ContactHuilian Zhu, professor
zhuhl@mail.sysu.edu.cn+86 20 87331811

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026